Pharmacelera Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.1M

  • Investors
  • 11

Pharmacelera General Information

Description

Developer of a drug discovery platform designed to explore large and diverse chemical spaces. The company's platform uses a 3D representation of molecules based on electrostatic, steric and hydrophobic interaction fields derived from semi-empirical quantum-mechanics calculations, enabling bioinformaticians and medicinal chemists to obtain results using benchmarked technology and boost their drug discovery projects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • PCB, Torre R, 4a planta, Despatx A05, Parc Científic de Barcelona
  • Carrer de Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain
+34 937
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Corporate Office
  • PCB, Torre R, 4a planta, Despatx A05, Parc Científic de Barcelona
  • Carrer de Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain
+34 937

Pharmacelera Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmacelera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 18-Feb-2026 $7.1M Completed Generating Revenue
7. Accelerator/Incubator 01-Jul-2024 Completed Generating Revenue
6. Later Stage VC 16-Jul-2023 Completed Generating Revenue
5. Equity Crowdfunding 05-May-2021 Completed Generating Revenue
4. Grant 02-Apr-2020 Completed Startup
3. Grant 08-Jan-2020 Completed Startup
2. Grant 23-Mar-2018 $61.6K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Pharmacelera’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pharmacelera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform designed to explore large and diverse chemical spaces. The company's platform use
Decision/Risk Analysis
Barcelona, Spain
24 As of 2026

Seattle, WA
 

Pune, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharmacelera Competitors (9)

One of Pharmacelera’s 9 competitors is Cyrus Biotechnology, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cyrus Biotechnology Venture Capital-Backed Seattle, WA
VLife Sciences Technologies Formerly PE-Backed Pune, India
BPS Bioscience Corporation San Diego, CA
Chemical Computing Group Private Equity-Backed Montreal, Canada
OpenEye Scientific Software Corporate Backed or Acquired Santa Fe, NM
You’re viewing 5 of 9 competitors. Get the full list »

Pharmacelera Patents

Pharmacelera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4555519-A1 Generating candidate molecule structure Pending 13-Jul-2022
WO-2024013028-A1 Generating candidate molecule structure Inactive 13-Jul-2022
EP-3563274-A1 Calculating molecular similarity Pending 29-Dec-2016
WO-2018121866-A1 Calculating molecular similarity Inactive 29-Dec-2016 G16C20/30

Pharmacelera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmacelera Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clave Capital Hedge Fund Minority
Inveready Asset Management Venture Capital Minority
Noso Capital PE/Buyout Minority
The Collider Accelerator/Incubator
AVANÇSA Government
You’re viewing 5 of 11 investors. Get the full list »

Pharmacelera FAQs

  • When was Pharmacelera founded?

    Pharmacelera was founded in 2011.

  • Where is Pharmacelera headquartered?

    Pharmacelera is headquartered in Barcelona, Spain.

  • What is the size of Pharmacelera?

    Pharmacelera has 24 total employees.

  • What industry is Pharmacelera in?

    Pharmacelera’s primary industry is Decision/Risk Analysis.

  • Is Pharmacelera a private or public company?

    Pharmacelera is a Private company.

  • What is Pharmacelera’s current revenue?

    The current revenue for Pharmacelera is .

  • How much funding has Pharmacelera raised over time?

    Pharmacelera has raised $8.96M.

  • Who are Pharmacelera’s investors?

    Clave Capital, Inveready Asset Management, Noso Capital, The Collider, and AVANÇSA are 5 of 11 investors who have invested in Pharmacelera.

  • Who are Pharmacelera’s competitors?

    Cyrus Biotechnology, VLife Sciences Technologies, BPS Bioscience, Chemical Computing Group, and OpenEye Scientific Software are some of the 9 competitors of Pharmacelera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process